Thomas Malley - Jun 22, 2022 Form 4 Insider Report for BeiGene, Ltd. (BGNE)

Role
Director
Signature
/s/ Qing Nian, as Attorney-in-Fact
Stock symbol
BGNE
Transactions as of
Jun 22, 2022
Transactions value $
$0
Form type
4
Date filed
6/24/2022, 05:37 PM
Previous filing
Jun 23, 2022
Next filing
Jun 30, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BGNE Ordinary Shares Award $0 +16.7K +97.72% $0.00 33.8K Jun 22, 2022 Direct F1
holding BGNE American Depositary Shares 30K Jun 22, 2022 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BGNE Share Option (Right to Buy) Award $0 +34.6K $0.00 34.6K Jun 22, 2022 Ordinary Shares 34.6K $11.98 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents securities underlying restricted share units. The restricted share units shall become fully vested on the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the director resigns from the board of directors or otherwise ceases to serve as a director, unless the board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events. The restricted share unites were granted under the Company's Independent Director Compensation Policy, as amended.
F2 Each American Depositary Share ("ADS") represents 13 ordinary shares.
F3 The number of securities underlying each option and the exercise price therefor are represented in ordinary shares.
F4 The option shall become exercisable in full upon the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the Reporting Person resigns from the board of directors or otherwise ceases to serve as a director, unless the board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events. The option was granted under the Company's Independent Director Compensation Policy, as amended.